•Cytyc Corporation is a company engaged in the design, development, manufacture, and marketing of clinical products that focus on women’s health since 1987. In order to overcome limitations on conventional pap, the company introduced the ThinPrep Pap Test. In May 1996, the Food and Drug Administration (FDA) in the USA approved the ThinPrep 2000( T 2000 ) as a replacement for the conventional Pap smear method in USA for use in screening for the presence of atypical cells, cervical cancer or its precursor lesions (Low Grade Squamous Intraepithelial Lesions, High Grade Squamous Intraepithelial Lesions), as well as all other cytologic categories . dr.vikram saraswat |Saraswat Pathology in Agra •The heart of the ThinPrep® System is the ThinPrep 2000 Processor, a semi automated slide preparation unit that produces remarkably uniform thin-layer slides, virtually free of obscuring artifacts such as blood, mucous and inflammation. Diagnosis, Diagnostics, and Efficient Treatment P...
Comments
Post a Comment